Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» emapalumab
emapalumab
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
Mon, 10/31/22 - 10:37 am
clinical trials
systemic lupus erythematosus
AbbVie
ABBV-509
Eli Lilly
LY3471851
Merck KGaA
M5049
Swedish Orphan Biovitrum
emapalumab
Sobi’s $50M bet on a rare disease drug pays off with a quick FDA nod
Endpoints
Tue, 11/20/18 - 08:33 pm
Sobi
FDA
emapalumab
Gamifant
HLH